Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06825715 · ClinicalTrials.gov registry record · NA
Multilevel Intervention for Precision Oncology
A NA study of Advanced Cancers of the Prostate and Cancers of the Lung, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 2,653
- Enrollment target
- 1
- Study location
NCT06825715 is a NA study of Advanced Cancers of the Prostate and Cancers of the Lung that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 2,653 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06825715, a NA study of Advanced Cancers of the Prostate and Cancers of the Lung, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,653 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, and 3: a change in the electronic medical record to make it easier to order and review results of Precision Oncology tests.
Conditions Studied
Interventions
- OTHER Multilevel intervention
Study Locations (1)
New York
- VA NY Harbor Healthcare System, New York, NY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,653 participants |
| Start Date | 2025-07-02 |
| Est. Completion | 2030-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06825715
The ClinicalTrials.gov registry entry for NCT06825715 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,653 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Advanced Cancers of the Prostate appearing as the primary indexed condition, and to 1 intervention - of which Multilevel intervention is the first listed.
NCT06825715 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06825715 about?
NCT06825715 is a clinical study titled "Multilevel Intervention for Precision Oncology". The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, an...
What is the current status of trial NCT06825715?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,653 participants. The study started on 2025-07-02. Estimated completion is 2030-02-28.
What conditions does trial NCT06825715 study?
This clinical trial studies the following conditions: Advanced Cancers of the Prostate, Cancers of the Lung.
What interventions are being tested in trial NCT06825715?
The interventions under investigation include: Multilevel intervention (OTHER).
Who is sponsoring clinical trial NCT06825715?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06825715 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.